https://touchneurology.com/epilepsy/conference-hub/william-rosenfeld-md-aan-2022-phase-iii-post-hoc-analysis-of-cenobamate-for-focal-onset-seizures/
William Rosenfeld, MD, AAN 2022: Phase III post-hoc analysis of cenobamate for focal-onset seizures...
Apr 29, 2022 - Cenobamate is approved in the United States for focal-onset seizures (partial-onset seizures) in adults both as adjunctive and monotherapy. In the EU,
post hoc analysisfocal onset seizuresphase iiiwilliamrosenfeld